GeoVax Stock Based Compensation from 2010 to 2025

GOVXW Stock

USD 0.05 0.03 36.12%

GeoVax Labs Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 516.7 K in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2007-03-31

Previous Quarter

101.6 K

Current Value

129.9 K

Quarterly Volatility

310 K

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.4 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 205, Dividend Yield of 0.0 or PTB Ratio of 2.61. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.

Check out the analysis of GeoVax Labs Correlation against competitors.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of GeoVax Labs over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. GeoVax Labs' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

GeoVax Stock Based Compensation Regression Statistics

	Arithmetic Mean	610,562
	Geometric Mean	409,427
	Coefficient Of Variation	82.24
	Mean Deviation	380,104
	Median	479,103
	Standard Deviation	502,150
	Sample Variance	252.2B
	Range	2M
	R-Value	(0.13)
	Mean Square Error	265.5B
	R-Squared	0.02
	Significance	0.63
	Slope	(13,798)
	Total Sum of Squares	3.8T

GeoVax Stock Based Compensation History

	2025	516.7 K
	2024	967.5 K
	2023	1.1 M
	2022	902.1 K
	2021	370 K
	2020	64.5 K
	2019	327.5 K

Other Fundumenentals of GeoVax Labs

Stock Based Compensation To Revenue

GeoVax Labs Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Good Will	Short Term Debt	Current Deferred Revenue	Intangible Assets	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Net Working Capital	Long Term Debt	Short Long Term Debt	Capital Stock
Total Assets		0.97	-0.98	-0.65	0.6	-0.26	0.66	1.0	-0.3	0.15	-0.27	0.1	-0.13	0.73	0.75	0.98	0.98	-0.76	-0.31	-0.78
Total Stockholder Equity	0.97		-0.96	-0.53	0.46	-0.18	0.48	0.97	-0.28	0.08	-0.19	0.05	-0.08	0.63	0.66	0.98	0.98	-0.64	-0.2	-0.67
Net Debt	-0.98	-0.96		0.55	-0.47	0.19	-0.66	-0.99	0.27	-0.16	0.22	-0.16	0.2	-0.69	-0.66	-0.97	-0.98	0.71	0.26	0.72
Retained Earnings	-0.65	-0.53	0.55		-0.94	0.44	-0.7	-0.62	0.27	-0.43	0.41	-0.31	0.36	-0.83	-0.81	-0.64	-0.57	0.85	0.53	0.88
Accounts Payable	0.6	0.46	-0.47	-0.94		-0.43	0.69	0.57	-0.38	0.35	-0.37	0.18	-0.2	0.77	0.86	0.55	0.49	-0.78	-0.46	-0.85
Net Receivables	-0.26	-0.18	0.19	0.44	-0.43		-0.38	-0.25	0.02	0.24	0.38	0.32	-0.23	-0.26	-0.24	-0.2	-0.19	0.28	0.28	0.28
Total Liab	0.66	0.48	-0.66	-0.7	0.69	-0.38		0.67	-0.21	0.24	-0.4	0.25	-0.23	0.78	0.62	0.58	0.58	-0.78	-0.44	-0.75
Total Current Assets	1.0	0.97	-0.99	-0.62	0.57	-0.25	0.67		-0.3	0.13	-0.27	0.09	-0.13	0.73	0.73	0.98	0.99	-0.75	-0.3	-0.77
Common Stock	-0.3	-0.28	0.27	0.27	-0.38	0.02	-0.21	-0.3		-0.05	0.43	0.01	-0.04	-0.37	-0.53	-0.27	-0.26	0.46	0.43	0.43
Good Will	0.15	0.08	-0.16	-0.43	0.35	0.24	0.24	0.13	-0.05		0.06	0.93	-0.95	0.29	0.29	0.2	0.18	-0.31	-0.28	-0.33
Short Term Debt	-0.27	-0.19	0.22	0.41	-0.37	0.38	-0.4	-0.27	0.43	0.06		0.13	-0.09	-0.42	-0.25	-0.24	-0.22	0.57	0.94	0.43
Current Deferred Revenue	0.1	0.05	-0.16	-0.31	0.18	0.32	0.25	0.09	0.01	0.93	0.13		-0.95	0.31	0.16	0.16	0.13	-0.26	-0.17	-0.22
Intangible Assets	-0.13	-0.08	0.2	0.36	-0.2	-0.23	-0.23	-0.13	-0.04	-0.95	-0.09	-0.95		-0.26	-0.18	-0.19	-0.18	0.28	0.24	0.26
Capital Surpluse	0.73	0.63	-0.69	-0.83	0.77	-0.26	0.78	0.73	-0.37	0.29	-0.42	0.31	-0.26		0.86	0.74	0.69	-0.96	-0.47	-0.94
Property Plant Equipment	0.75	0.66	-0.66	-0.81	0.86	-0.24	0.62	0.73	-0.53	0.29	-0.25	0.16	-0.18	0.86		0.73	0.7	-0.87	-0.34	-0.95
Net Invested Capital	0.98	0.98	-0.97	-0.64	0.55	-0.2	0.58	0.98	-0.27	0.2	-0.24	0.16	-0.19	0.74	0.73		0.99	-0.75	-0.3	-0.78
Net Working Capital	0.98	0.98	-0.98	-0.57	0.49	-0.19	0.58	0.99	-0.26	0.18	-0.22	0.13	-0.18	0.69	0.7	0.99		-0.72	-0.28	-0.74
Long Term Debt	-0.76	-0.64	0.71	0.85	-0.78	0.28	-0.78	-0.75	0.46	-0.31	0.57	-0.26	0.28	-0.96	-0.87	-0.75	-0.72		0.64	0.97
Short Long Term Debt	-0.31	-0.2	0.26	0.53	-0.46	0.28	-0.44	-0.3	0.43	-0.28	0.94	-0.17	0.24	-0.47	-0.34	-0.3	-0.28	0.64		0.52
Capital Stock	-0.78	-0.67	0.72	0.88	-0.85	0.28	-0.75	-0.77	0.43	-0.33	0.43	-0.22	0.26	-0.94	-0.95	-0.78	-0.74	0.97	0.52

Click cells to compare fundamentals

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	967.5 K	516.7 K
Stock Based Compensation To Revenue	10.02	10.52

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeoVax Stock Based Compensation from 2010 to 2025

Latest GeoVax Labs' Stock Based Compensation Growth Pattern

GeoVax Stock Based Compensation Regression Statistics

GeoVax Stock Based Compensation History

Other Fundumenentals of GeoVax Labs

GeoVax Labs Stock Based Compensation component correlations

About GeoVax Labs Financial Statements

Also Currently Popular

Additional Tools for GeoVax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY